These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 26303600

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Expression patterns of parathyroid hormone-related peptide (PTHrP) and parathyroid hormone receptor type 1 (PTHR1) during human development are suggestive of roles specific for each gene that are not mediated through the PTHrP/PTHR1 paracrine signaling pathway.
    Cormier S, Delezoide AL, Silve C.
    Gene Expr Patterns; 2003 Mar; 3(1):59-63. PubMed ID: 12609604
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and hypoparathyroidism - translating the pharmacology.
    Tay D, Cremers S, Bilezikian JP.
    Br J Clin Pharmacol; 2018 Feb; 84(2):252-267. PubMed ID: 29049872
    [Abstract] [Full Text] [Related]

  • 26. Development of Potent, Protease-Resistant Agonists of the Parathyroid Hormone Receptor with Broad β Residue Distribution.
    Cheloha RW, Chen B, Kumar NN, Watanabe T, Thorne RG, Li L, Gardella TJ, Gellman SH.
    J Med Chem; 2017 Nov 09; 60(21):8816-8833. PubMed ID: 29064243
    [Abstract] [Full Text] [Related]

  • 27. Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo.
    Ho PW, Goradia A, Russell MR, Chalk AM, Milley KM, Baker EK, Danks JA, Slavin JL, Walia M, Crimeen-Irwin B, Dickins RA, Martin TJ, Walkley CR.
    Oncogene; 2015 May 28; 34(22):2922-33. PubMed ID: 25043296
    [Abstract] [Full Text] [Related]

  • 28. Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors.
    Hoare SR, Usdin TB.
    Curr Pharm Des; 2001 May 28; 7(8):689-713. PubMed ID: 11375776
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Parathyroid Hormone-Related Protein Negatively Regulates Tumor Cell Dormancy Genes in a PTHR1/Cyclic AMP-Independent Manner.
    Johnson RW, Sun Y, Ho PWM, Chan ASM, Johnson JA, Pavlos NJ, Sims NA, Martin TJ.
    Front Endocrinol (Lausanne); 2018 May 28; 9():241. PubMed ID: 29867773
    [Abstract] [Full Text] [Related]

  • 31. [Hormones and osteoporosis update. Histological aspects on the action of parathyroid hormone (PTH) and PTH-related peptide (PTHrP) on bone and cartilage].
    Amizuka N, Li M, Tamura M, Oda K.
    Clin Calcium; 2009 Jul 28; 19(7):935-43. PubMed ID: 19567988
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Conformational changes in the parathyroid hormone receptor associated with activation by agonist.
    Thomas BE, Woznica I, Mierke DF, Wittelsberger A, Rosenblatt M.
    Mol Endocrinol; 2008 May 28; 22(5):1154-62. PubMed ID: 18258686
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Translating in vitro ligand bias into in vivo efficacy.
    Luttrell LM, Maudsley S, Gesty-Palmer D.
    Cell Signal; 2018 Jan 28; 41():46-55. PubMed ID: 28495495
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.